Cargando…

Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study

Evaluation of airway inflammation is important in achieving adequate dosing of inhaled corticosteroids (ICS) for treating bronchial asthma. However, there is no evaluation tool that can be used in clinical settings. We examined biomarkers that can precisely reflect airway inflammation when ICS are d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Go, Takahashi, Koichiro, Izuhara, Kenji, Komiya, Kazutoshi, Kimura, Shinya, Hayashi, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738382/
https://www.ncbi.nlm.nih.gov/pubmed/23943655
http://dx.doi.org/10.4137/BMI.S12537
_version_ 1782476834757148672
author Kato, Go
Takahashi, Koichiro
Izuhara, Kenji
Komiya, Kazutoshi
Kimura, Shinya
Hayashi, Shinichiro
author_facet Kato, Go
Takahashi, Koichiro
Izuhara, Kenji
Komiya, Kazutoshi
Kimura, Shinya
Hayashi, Shinichiro
author_sort Kato, Go
collection PubMed
description Evaluation of airway inflammation is important in achieving adequate dosing of inhaled corticosteroids (ICS) for treating bronchial asthma. However, there is no evaluation tool that can be used in clinical settings. We examined biomarkers that can precisely reflect airway inflammation when ICS are decreased in stable asthmatic patients. This was a 12-week, single-arm, open-label clinical study performed at a single university hospital. Twenty-five patients (6 male and 19 female) with stable asthma were included in this study. We investigated whether the levels of nitrite and nitrate in exhaled breath condensate (EBC) increase after ICS reduction. We also investigated whether blood eosinophils, serum immunoglobulin E (IgE), high-sensitivity C reactive protein (hs-CRP), interleukin (IL)-13, IL-17, and periostin are different before and after ICS reduction. Peak expiratory flow (PEF), pulmonary function tests, asthma control test (ACT), and asthma quality of life questionnaire (AQLQ) were also examined. We considered an unscheduled hospital visit due to asthmatic symptoms and decline in average PEF over one week by more than 10% to indicate disease instability, and compared patients with stable and unstable disease for analysis. Unstable status was detected in 5 patients. Age, sex, asthma duration, ACT and AQLQ scores, and the level of serum IgE did not differ between stable and unstable groups. In the unstable group, the total concentration of nitrite and nitrate at the last visit was 9.84 (6.65–11.24) μM. Surprisingly, this was similar to the concentration at the first visit (5.58 (2.94–17.29) μM). Serum periostin before ICS reduction (141.9 [107.7–147.7] pg/mL) was higher in the unstable group than in the stable group (91.5 [78.75–103.5] pg/mL). The unstable group had a higher peripheral blood eosinophil count and wider diurnal variation of PEF at the first visit compared to the stable group. Higher eosinophils in peripheral blood and wider diurnal variation of PEF were predictive markers for unstable disease after ICS reduction. Serum periostin is another candidate for the predictive marker.
format Online
Article
Text
id pubmed-3738382
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-37383822013-08-13 Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study Kato, Go Takahashi, Koichiro Izuhara, Kenji Komiya, Kazutoshi Kimura, Shinya Hayashi, Shinichiro Biomark Insights Original Research Evaluation of airway inflammation is important in achieving adequate dosing of inhaled corticosteroids (ICS) for treating bronchial asthma. However, there is no evaluation tool that can be used in clinical settings. We examined biomarkers that can precisely reflect airway inflammation when ICS are decreased in stable asthmatic patients. This was a 12-week, single-arm, open-label clinical study performed at a single university hospital. Twenty-five patients (6 male and 19 female) with stable asthma were included in this study. We investigated whether the levels of nitrite and nitrate in exhaled breath condensate (EBC) increase after ICS reduction. We also investigated whether blood eosinophils, serum immunoglobulin E (IgE), high-sensitivity C reactive protein (hs-CRP), interleukin (IL)-13, IL-17, and periostin are different before and after ICS reduction. Peak expiratory flow (PEF), pulmonary function tests, asthma control test (ACT), and asthma quality of life questionnaire (AQLQ) were also examined. We considered an unscheduled hospital visit due to asthmatic symptoms and decline in average PEF over one week by more than 10% to indicate disease instability, and compared patients with stable and unstable disease for analysis. Unstable status was detected in 5 patients. Age, sex, asthma duration, ACT and AQLQ scores, and the level of serum IgE did not differ between stable and unstable groups. In the unstable group, the total concentration of nitrite and nitrate at the last visit was 9.84 (6.65–11.24) μM. Surprisingly, this was similar to the concentration at the first visit (5.58 (2.94–17.29) μM). Serum periostin before ICS reduction (141.9 [107.7–147.7] pg/mL) was higher in the unstable group than in the stable group (91.5 [78.75–103.5] pg/mL). The unstable group had a higher peripheral blood eosinophil count and wider diurnal variation of PEF at the first visit compared to the stable group. Higher eosinophils in peripheral blood and wider diurnal variation of PEF were predictive markers for unstable disease after ICS reduction. Serum periostin is another candidate for the predictive marker. Libertas Academica 2013-08-04 /pmc/articles/PMC3738382/ /pubmed/23943655 http://dx.doi.org/10.4137/BMI.S12537 Text en © 2013 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article published under the Creative Commons CC-BY-NC 3.0 license.
spellingShingle Original Research
Kato, Go
Takahashi, Koichiro
Izuhara, Kenji
Komiya, Kazutoshi
Kimura, Shinya
Hayashi, Shinichiro
Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
title Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
title_full Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
title_fullStr Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
title_full_unstemmed Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
title_short Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study
title_sort markers that can reflect asthmatic activity before and after reduction of inhaled corticosteroids: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738382/
https://www.ncbi.nlm.nih.gov/pubmed/23943655
http://dx.doi.org/10.4137/BMI.S12537
work_keys_str_mv AT katogo markersthatcanreflectasthmaticactivitybeforeandafterreductionofinhaledcorticosteroidsapilotstudy
AT takahashikoichiro markersthatcanreflectasthmaticactivitybeforeandafterreductionofinhaledcorticosteroidsapilotstudy
AT izuharakenji markersthatcanreflectasthmaticactivitybeforeandafterreductionofinhaledcorticosteroidsapilotstudy
AT komiyakazutoshi markersthatcanreflectasthmaticactivitybeforeandafterreductionofinhaledcorticosteroidsapilotstudy
AT kimurashinya markersthatcanreflectasthmaticactivitybeforeandafterreductionofinhaledcorticosteroidsapilotstudy
AT hayashishinichiro markersthatcanreflectasthmaticactivitybeforeandafterreductionofinhaledcorticosteroidsapilotstudy